1. Home
  2. TRT vs AYTU Comparison

TRT vs AYTU Comparison

Compare TRT & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRT
  • AYTU
  • Stock Information
  • Founded
  • TRT 1958
  • AYTU N/A
  • Country
  • TRT United States
  • AYTU United States
  • Employees
  • TRT N/A
  • AYTU N/A
  • Industry
  • TRT Industrial Machinery/Components
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRT Technology
  • AYTU Health Care
  • Exchange
  • TRT Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • TRT 22.7M
  • AYTU 18.8M
  • IPO Year
  • TRT N/A
  • AYTU N/A
  • Fundamental
  • Price
  • TRT $6.22
  • AYTU $2.33
  • Analyst Decision
  • TRT
  • AYTU Strong Buy
  • Analyst Count
  • TRT 0
  • AYTU 3
  • Target Price
  • TRT N/A
  • AYTU $9.17
  • AVG Volume (30 Days)
  • TRT 15.9K
  • AYTU 381.3K
  • Earning Date
  • TRT 11-11-2025
  • AYTU 11-12-2025
  • Dividend Yield
  • TRT N/A
  • AYTU N/A
  • EPS Growth
  • TRT N/A
  • AYTU N/A
  • EPS
  • TRT N/A
  • AYTU N/A
  • Revenue
  • TRT $36,473,000.00
  • AYTU $66,382,000.00
  • Revenue This Year
  • TRT N/A
  • AYTU N/A
  • Revenue Next Year
  • TRT N/A
  • AYTU $19.03
  • P/E Ratio
  • TRT N/A
  • AYTU N/A
  • Revenue Growth
  • TRT N/A
  • AYTU 1.84
  • 52 Week Low
  • TRT $4.62
  • AYTU $0.95
  • 52 Week High
  • TRT $7.88
  • AYTU $2.82
  • Technical
  • Relative Strength Index (RSI)
  • TRT 64.98
  • AYTU 55.70
  • Support Level
  • TRT $5.61
  • AYTU $1.65
  • Resistance Level
  • TRT $6.20
  • AYTU $1.98
  • Average True Range (ATR)
  • TRT 0.24
  • AYTU 0.16
  • MACD
  • TRT 0.07
  • AYTU 0.01
  • Stochastic Oscillator
  • TRT 77.24
  • AYTU 64.35

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: